4.8 Article

Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells

期刊

ACTA BIOMATERIALIA
卷 6, 期 6, 页码 1904-1916

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2009.12.005

关键词

Embryonic stem cell; Patterning; Endothelial cell; Smooth muscle cell; VEGF

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. National Sciences and Engineering Research Council of Canada (NSERC) [RMF-72557, RGPIN 293170-04, RGPIN 326982-06]
  3. Heart and Stroke Foundation of Ontario (HSFO) [NA 6077]
  4. HSFO
  5. Canada Research Chair

向作者/读者索取更多资源

Differentiation of stem and progenitor cells routinely relies on the application of soluble growth factors, an approach that enables temporal control of cell fate but enables no spatial control of the differentiation process. Angiogenic progenitor cells derived from mouse embryonic stem cells (ESCs) were differentiated here according to the pattern of immobilized vascular endothelial growth factor-A (VEGF). Mouse ESCs engineered to express green fluorescent protein (eGFP) under control of promoter for the receptor tyrosine kinase Flk1 were used. The Flk1+ angiogenic progenitors were selected from day 3 differentiating embryoid bodies based on their expression of eGFP using fluorescence activated cell sorting. Mouse VEGF(165) was covalently immobilized onto collagen IV (ColIV) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) chemistry. A non-cell adhesive layer of photocrosslinkable chitosan was first created, after which VEGF-ColIV was stamped as 100 mu m wide lanes on top of the chitosan layer and the Flk1+ angiogenic progenitors were seeded for site-specific differentiation. Lanes stamped with only ColIV served as controls. The results presented here demonstrate that the cultivation of Flk1+ progenitors on surfaces with immobilized VEGF yielded primarily endothelial cells (53 +/- 13% CD31 positive and 17 +/- 2% smooth muscle actin positive), whereas surfaces without VEGF favored vascular smooth muscle-like cell differentiation (26 +/- 17% CD31 positive and 38 +/- 9% smooth muscle actin positive). (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据